Recombinant Human IL-1α
Recombinant Human IL-1α
Product No.: I-182
- -
- -
Alternate Names Interleukin-1 Alpha, Hematopoietin-1, Lymphocyte-Activating Factor [LAF], Endogenous Pyrogen [EP], Leukocyte Endogenous Mediator [LEM], Mononuclear Cell Factor [MCF] Product Type Recombinant Protein Expression Host E. coli Cells Species Human |
Data
- -
- -
BackgroundIL-1R1 is an 80 kD transmembrane glycoprotein and a member of the Ig superfamily. IL-1 binds both IL-1R1 and IL-1R2. The ligands IL-1α and IL-1β only commence when binding IL-1R1 because IL-1R2 acts as a decoy receptor and competitively antagonizes the binding of IL-1α and IL-1β, thereby reducing their biological effects. Binding of the ligands to IL-1R1 is enhanced by an accessory protein, IL-1R-AcP. IL-1α can exist as either a 31 kD precursor or an 18 kD mature form. IL-1α is a proinflammatory cell-associated cytokine and IL-1β is a 17.5 kD proinflammatory secreted cytokine. Both IL-1α and IL-1β bind to the same receptor and have similar properties that include stimulation of thymocyte proliferation via IL-2 release, B-cell maturation and proliferation, mitogenic FGF-like activity and the ability to stimulate the release of prostaglandin and collagenase from synovial cells. Furthermore, IL-1β mediates a variety of immune and inflammatory responses. IL-1β is a major cause of severe inflammation in the mouse model of Crohn’s Disease, which makes IL-1β an important target for this disease. Protein DetailsPurity >97% by SDS-PAGE and analyzed by silver stain. Endotoxin Level <0.1 EU/µg as determined by the LAL method Biological Activity The biological activity of Human IL-1 Alpha was determined in a cell proliferation assay using the murine helper T cell line, D10.G4.1 (Symons, J.A. et al., in Lymphokines and Interferons, a Practical Approach, 1987, M.J. Clemens, A.G. Morris, and A.J.H. Gearing, eds., IRL Press, p. 272). The expected ED<sub>50</sub> for this effect is typically 3 - 7 pg/ml. Protein Accession No. Q53QF9 Amino Acid Sequence sapfsfls nvkynfmrii kyefilndal nqsiirandq yltaaalhnl deavkfdmga yksskddaki tvilrisktq lyvtaqdedq pvllkempei pktitgsetn llffwethgt knyftsvahp nlfiatkqdy wvclaggpps itdfqilenq a N-terminal Sequence Analysis Ser113 State of Matter Solution Predicted Molecular Mass The predicted molecular weight of Recombinant Human IL-1α is Mr 18 kDa. Additionally, the actual molecular weight as observed by migration on SDS-PAGE is 18 kDa (reducing conditions). Predicted Molecular Mass 18 Formulation This recombinant protein solution was 0.2 µm filtered and formulated in modified Dulbecco’s phosphate buffered saline (1X PBS) pH 7.2 – 7.3 with no calcium, magnesium, or preservatives present. Storage and Stability Working aliquots of human rIL-1 alpha are stable for up to twelve months at -20° C to -70° C in a manual defrost freezer. Upon thawing, rIL-1 alpha, in the presence of a carrier protein, can be stored at 2° - 8°C for one month without detectable loss of activity. For long-term storage, aliquot and freeze at -20° C to -70° C in a manual defrost freezer. Avoid repeated freeze thaw cycles. Country of Origin USA Shipping Dry Ice References & Citations1. Arend, WP. et al. (2003) Cytokine Growth Factor Rev. 13:323 2. Nicklin, MJ. et al. (1994) Genomics 19:382 3. Dunn, E. et al. (2001) Trends Immunol. 22:533 4. Hardy, R. et al. (2009) J. Endocrinol. 201:309 Certificate of AnalysisIMPORTANT Use lot specific datasheet for all technical information pertaining to this recombinant protein. |
Related Products
- -
- -
Prod No. | Description |
---|---|
I-658 | |
I-628 | |
I-182 | |
I-671 | |
I-144 | |
I-161 | |
I-341 | |
I-653 | |
I-204 | |
I-334 |
